Blog2024-07-01T14:28:28-05:00

Support for clinicians impacted by California wildfires

On Feb. 3, the Centers for Medicare & Medicaid Services (CMS) announced that the “Extreme and Uncontrollable Circumstances Exception” policy will be applied to Merit-based Incentive Payment System (MIPS) eligible clinicians who have been impacted by the wildfires [...]

February 6th, 2025|Payer Advocacy|

Sleep Medicine Weekly Insider – February 1, 2025

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Actigraphy wearables webinar is Feb. 7 The AASM Emerging Technology Committee is hosting [...]

February 1st, 2025|Weekly Insider|

Sleep Medicine Weekly Insider – January 25, 2025

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Apply for autoscoring Gold Standard Panel Early career registered sleep technologists are invited [...]

January 25th, 2025|Weekly Insider|

CMS accepting MIPS submissions through March 31

On Jan. 3, the Centers for Medicare & Medicaid Services (CMS) announced that Merit-Based Incentive Payment System (MIPS) submissions for the Quality Payment Program (QPP) can now be submitted and updated through 8 p.m. ET on March 31, 2025. [...]

January 23rd, 2025|Payer Advocacy|

Sleep Medicine Weekly Insider – January 18, 2025

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Explore novel drugs for sleep apnea To give clinicians an overview of novel drugs [...]

January 18th, 2025|Weekly Insider|

Case Study of the Month – January 2025

The AASM Case Study of the Month for January is about an eight-year-old girl with no significant medical history who presented with worsening excessive daytime sleepiness (EDS) over the past year. Despite adenotonsillectomy for mild obstructive sleep apnea, [...]

January 17th, 2025|Case Study of the Month|

Sleep Medicine Weekly Insider – January 11, 2025

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Medicare coverage of Zepbound for OSA Medicare drug plans can now cover Zepbound [...]

January 11th, 2025|Weekly Insider|

CMS updates guidance on code G2211

The Centers for Medicare & Medicaid Services (CMS) has posted the revised resource, “How to Use the Office & Outpatient Evaluation and Management Visit Complexity Add-On Code G2211.” The code G2211 reflects visit complexity and increases the value of [...]

January 9th, 2025|Payer Advocacy|

Sleep Medicine Weekly Insider – January 4, 2025

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. AASM is celebrating 50 years in 2025 Established in 1975, the AASM is [...]

January 4th, 2025|Weekly Insider|

AASM congratulates the 2025 membership renewal drawing winners

We’re thrilled to announce the winners of the 2025 AASM membership renewal drawing! Thank you to everyone who renewed their membership early and participated in this exciting opportunity. Congratulations to the following winners: AASM Premium Gold Certificate Holder Peter [...]

December 26th, 2024|Membership|

Zepbound approved by FDA as first sleep apnea medication

On Dec. 20, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. Read the FDA press release announcing Zepbound's approval for sleep apnea. [...]

December 21st, 2024|Industry|
Go to Top